Loading…
Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma
Hanna, G.J., Woo, S.-B., Li, Y.Y., Barletta, J.A., Hammerman, P.S., Lorch, J.H.
Published in International journal of oral and maxillofacial surgery (01.05.2018)
Published in International journal of oral and maxillofacial surgery (01.05.2018)
Get full text
Journal Article
Loading…
Loading…
AI-based radiomic biomarkers to predict PD-(L)1 immune checkpoint inhibitor response within PD-L1 high/low/negative expression categories in stage IV NSCLC
Jordan, Petr, Sako, Chiharu, Beasley, Ryan, Owen, Dwight Hall, Patel, Arpan, Curti, Brendan D., Weerasinghe, Roshanthi K., Lee, Soohee, Amini, Arya, Liu, An, Page, Ray D., Swalduz, Aurélie, Beregi, Jean-Paul, Sanchez, Stéphane, Gevaert, Olivier, Parikh, Ravi Bharat, Aerts, Hugo
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Loading…
Loading…
PD-L1 overexpression in prostate cancer: a potential targeted therapy
Aditya, Gede Andi, Dany, Yurisal Akhmad, Danarto, Raden, Soeroharjo, Indrawarman, Hendri, Ahmad Zulfan
Published in Bali medical journal (01.08.2023)
Published in Bali medical journal (01.08.2023)
Get full text
Journal Article
Loading…
Adipose-Tissue-Derived Mesenchymal Stem Cells Mediate PD-L1 Overexpression in the White Adipose Tissue of Obese Individuals, Resulting in T Cell Dysfunction
Eljaafari, Assia, Pestel, Julien, Le Magueresse-Battistoni, Brigitte, Chanon, Stephanie, Watson, Julia, Robert, Maud, Disse, Emmanuel, Vidal, Hubert
Published in Cells (Basel, Switzerland) (01.10.2021)
Published in Cells (Basel, Switzerland) (01.10.2021)
Get full text
Journal Article
Loading…
Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma
Chatterjee, Aniruddha, Rodger, Euan J., Ahn, Antonio, Stockwell, Peter A., Parry, Matthew, Motwani, Jyoti, Gallagher, Stuart J., Shklovskaya, Elena, Tiffen, Jessamy, Eccles, Michael R., Hersey, Peter
Published in iScience (29.06.2018)
Published in iScience (29.06.2018)
Get full text
Journal Article
Loading…
Interim results of a first-in-human phase 1 study of Q-1802, a CLDN18.2/PD-L1 bsABs, in patients with relapsed or refractory solid tumors
Yk, Wang, Gong, Jifang, Sun, Yuping, Zhang, Jian, Ni, Shuqin, Hou, Jie, Chen, Xiaohua, Wang, Yusheng, Yu, Qin, Qu, Xiangdong, Du, Yejie, Wei, Li, Yu, Tao, Shen, Lin
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Loading…
Tumor-Infiltrating Immune Cells and PD-L1 as Prognostic Biomarkers in Primary Esophageal Small Cell Carcinoma
Lin, Xianjie, Zhang, Hao, Huang, Haihua, Lin, Wan, Lin, Yusheng, Zhang, Fan, Kuang, Liping, Ni, Yangpeng, Ke, Xiurong, Wu, Xiao, Xiong, Xiao
Published in Journal of immunology research (2020)
Published in Journal of immunology research (2020)
Get full text
Journal Article
Loading…
A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors
Keam, Bhumsuk, Ock, Chan-Young, Kim, Tae Min, Oh, Do-Youn, Kang, Won Ki, Park, Yeon Hee, Lee, Jeeyun, Lee, Ji Hye, Ahn, Yoen Hee, Kim, Hyeon Ju, Chang, Sook Kyung, Park, Jihyun, Choi, Ji Yea, Song, Yun Jeong, Park, Young Suk
Published in Investigational new drugs (01.12.2021)
Published in Investigational new drugs (01.12.2021)
Get full text
Journal Article
Loading…
Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry
SAYGIN, İSMAİL, ÇAKIR, EMEL, KAZAZ, SEHER NAZLI, GÜVERCİN, ALİ RIZA, EYÜPOĞLU, İLKER, USTAOĞLU, MÜŞERREF MÜGE
Published in Turkish journal of medical sciences (01.01.2024)
Published in Turkish journal of medical sciences (01.01.2024)
Get full text
Journal Article
Loading…
Preliminary safety, efficacy, and pharmacokinetics (PK) results of KN046 (bispecific anti-PD-L1/CTLA4) from a first-in-human study in subjects with advanced solid tumors
Coward, Jermaine, Ganju, Vinod, Behzadigohar, Ramin, Kwong, Kenneth, Xu, June, Van, Hardy, Kong, Paul, Yang, Fei, Chen, Lisa, Guo, Kangping, Liu, Mei, Zhu, Danming, Donato, Lara Kristina, Xu, Ting, Richardson, Gary Edward
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
Association of PD-L1 Expression with Lymph Node Metastasis and Clinical Stage in Ampulla of Vater Cancer: An Observational Study
Andrianto, Andrianto, Rudiman, Reno, Ruchimat, Tommy, Lukman, Kiki, Sulthana, Bambang Am Am Setya, Purnama, Andriana, Wijaya, Alma, Primastari, Etis, Nugraha, Prapanca
Published in Cancer management and research (01.01.2025)
Published in Cancer management and research (01.01.2025)
Get full text
Journal Article
Loading…
Monocyte-derived Galectin-9 and PD-L1 differentially impair adaptive and innate immune response in chronic HBV infection and their expression remain unaltered after antiviral therapy
Dey, Debangana, Biswas, Satabdi, Pal, Sourina, Nandi, Sarthak, Khatun, Najma, Jha, Rambha, Chakraborty, Bidhan Chandra, Baidya, Ayana, Ghosh, Ranajoy, Banerjee, Soma, Ahammed, SK Mahiuddin, Chowdhury, Abhijit, Datta, Simanti
Published in Frontiers in immunology (09.10.2024)
Published in Frontiers in immunology (09.10.2024)
Get full text
Journal Article
Loading…
Safety and efficacy of PD-L1 inhibitor durvalumab with R-CHOP or R 2 -CHOP in subjects with previously untreated, high-risk DLBCL
Nowakowski, Grzegorz S., Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas Stauffer, Patel, Krish, Jäger, Ulrich, Manges, Robert F., Trumper, Lorenz H., Haioun, Corinne, Everaus, Hele, Kalakonda, Nagesh, Knoble, Jeanna, Brown, Peter, Joergensen, Judit Meszaros, Cunningham, David, Domper, Neus, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
Preliminary population pharmacokinetics supports phase II dose selection for masked anti-PD-L1 antibody CX-072
Stroh, Mark, Green, Michelle, Millard, Bjorn L., Garner, William, Lu, Hong, Richardson, Jennifer Hope, Hannah, Alison L.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Loading…
Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis
Nie, Run-Cong, Chen, Guo-Ming, Wang, Yun, Zhou, Jie, Duan, Jin-Ling, Zhou, Zhi-Wei, Yuan, Shu-Qiang
Published in Frontiers in oncology (19.03.2021)
Published in Frontiers in oncology (19.03.2021)
Get full text
Journal Article
Loading…
PD-L1 Expression in Different Segments and Histological Types of Ovarian Cancer According to Lymphocytic Infiltrate
Jovanović, Ljubiša, Janković, Radmila, Ćirković, Andja, Jović, Milena, Janjić, Tijana, Djuričić, Slaviša, Milenković, Svetlana
Published in Medicina (Kaunas, Lithuania) (29.11.2021)
Published in Medicina (Kaunas, Lithuania) (29.11.2021)
Get full text
Journal Article